News

NewBiologix was founded with a mission to revolutionize production of adenoassociated virus (AAV) vectors, focusing on high quality and reduced risk in both manufacturing and patient treatment.
Presented are highlights of the manufacturing trends that have reshaped the capacity landscape to our current state and explore the potential impact of currently developing events on both supply and ...
Learn about the numerous benefits of using a high-quality GMP-grade plasmid platform when manufacturing your pharmaceuticals.
Learn about a new purification approach starting from E. coli through to mRNA production, resulting in improved recoveries, extra-low protein impurities, and very efficient dsRNA removal.
Ingress of carbon dioxide into bulk drug substance (BDS) containers that are stored and shipped on dry ice is a serious and often understated problem. Bottles are a container of choice for freezing ...
Jing Guo, Research Scientist, MITThis interview features: Jing Guo, Research Scientist, MIT, from BioProcess International 2023.
Explore the latest news and expert commentary by Inês do Carmo Gonçalves, brought to you by the Contributor of BioProcess International.
You want to scale and deliver your vaccine to the world quickly. Our collaborative global vaccine capabilities will take your innovation from pre-clinical to full-scale GMP-manufacturing efficiently, ...
Working with the right partner for cell & gene therapies can help ease the increasingly common problems with scale, access to high-demand raw material, viral vector production, and quality ...
Pharmaceutical and biopharmaceutical manufacturing relies on the timely and seamless orchestration of many steps to meet aggressive timelines and ensure operational efficiency. A fundamental element ...
Vaccines have been protecting against disease since the late 1700s. They function by triggering the immune system to generate short-term and long-term responses. Because there are many pathogens, ...
This research project focused on a reactor for virus inactivation with UV light. The focal question: Can UV radiation be used to reliably inactivate viruses in a sensitive blood plasma solution?